Article
Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
The journal of gene medicine - 1 Oct 2018
Noureddini Mahdi, Mobasseri Narges, Karimian Mohammad, Behjati Mohaddeseh, Nikzad Hossein
Abstract excerpt
BACKGROUND: The Arg399Gln polymorphism in the X-ray repair cross-complementing group 1 gene (XRCC1) may alter the risk of prostate cancer (PCa). The present study aimed to investigate the association of the XRCC1-Arg399Gln polymorphism with PCa risk in an Iranian population, as followed by a meta-analysis and an in silico analysis. METHODS: In a case-control study, 360 subjects were included (180 men with PCa and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
